![Dolores Schendel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dolores Schendel
Direttore Tecnico/Scientifico/R&S presso MEDIGENE AG
Patrimonio netto: 1 M $ in data 30/06/2024
Posizioni attive di Dolores Schendel
Società | Posizione | Inizio | Fine |
---|---|---|---|
MEDIGENE AG | Direttore Tecnico/Scientifico/R&S | 01/05/2014 | - |
Amministratore Delegato | 31/08/2018 | 24/07/2022 | |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Amministratore Delegato | - | - |
Storia della carriera di Dolores Schendel
Precedenti posizioni note di Dolores Schendel
Società | Posizione | Inizio | Fine |
---|---|---|---|
Institute of Molecular Immunology | Direttore/Membro del Consiglio | 01/01/1998 | 01/01/2013 |
European Research Council
![]() European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Corporate Officer/Principal | - | - |
German Cancer Aid | Corporate Officer/Principal | - | - |
Deutsche Forschungsgemeinschaft | Corporate Officer/Principal | - | - |
Medigene Immunotherapies GmbH
![]() Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Amministratore Delegato | 01/05/2014 | - |
Fondatore | 01/05/2014 | - | |
Ludwig-Maximilians-Universität München | Corporate Officer/Principal | - | - |
Formazione di Dolores Schendel
University of Wisconsin | Doctorate Degree |
Statistiche
Distribuzione geografica
Germania | 7 |
Stati Uniti | 3 |
Belgio | 2 |
Posizioni
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Settori
Health Technology | 4 |
Consumer Services | 4 |
Miscellaneous | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
MEDIGENE AG | Health Technology |
Aziende private | 5 |
---|---|
Institute of Molecular Immunology | |
Medigene Immunotherapies GmbH
![]() Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Health Technology |
German Cancer Aid | |
European Research Council
![]() European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Miscellaneous |
MediGene, Inc.
![]() MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Dolores Schendel
- Esperienza